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Abstract
With the availability of longitudinal data, age-specific (stratified) or age-adjusted genetic analyses
have the potential to localize different putative trait influencing loci. If age does not influence the
locus-specific penetrance function within the range examined, age-stratified analyses will tend to
yield comparable results for an individual trait. However, age-stratified results should vary across
age strata when the locus-specific penetrance function is age dependent. In this paper, age-stratified
and age-adjusted quantitative trait loci (QTL) linkage analyses were contrasted for height, weight,
body mass index (BMI), and systolic blood pressure on a subset of the Framingham Heart Study.
The strata comprised individuals with data present in each of three age groups: 31–49, 50–60, 61–
79. Genome-wide QTL analyses were performed using SOLAR. Over all ages, a linkage signal for
height was detected on chromosome 14q11.2 near marker GATA74E02A (LOD for ages 31–49 =
2.38, LOD for ages 50–60 = 1.84, LOD for ages 61–79 = 2.45). Evidence of linkage to BMI in the
31–49 age group was found on chromosome 3q22 (GATA3C02, LOD = 2.89, p = 0.0003) at the
same location as the signal for weight (LOD = 3.10, p = 0.0002). Linkage was also supported on
chromosome 1p22.1 for BMI (LOD = 2.21, p = 0.0014) and weight (LOD = 2.47, p = 0.0007) in the
31–49 age group. Our age-stratified results suggest that QTL that are expressed over long periods
of time and affecting multiple, correlated traits may be identified using genome scan and variance-
component methodology to help detect early and/or late gene expression.
Background
While it has long been known that age is a major risk fac-
tor for cardiovascular disease (CVD), it is unclear how to
best capitalize upon this source of variation in the search
for CVD-predisposing genes. In particular, identifying
those strategies that might take advantage of a penetrance
function (probability of affection given a genotype) for a
disease that varies with age. Although parametric linkage
analysis models have incorporated age-specific pene-
trance in the likelihood calculations, nonparametric link-
age analysis has not. Similarly, methods of analysis for
quantitative traits (e.g., variance-component methods)
typically incorporate age as a covariate in analytic models.
Franklin et al. [1] report a shift in favor of pulse pressure
(PP) and systolic blood pressure (SBP) as significant pre-
dictors of coronary heart disease (CHD) risk at age 60 and
above, while diastolic blood pressure is a stronger predic-
tor of CHD while under 50. Between the ages 50 and 60,
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all are similarly predictive. This suggests that within indi-
viduals the expressivity of these moderately heritable
traits may be dependent upon age. However, not all traits
are influenced by measured covariates. For example,
height is likely not age-dependent between ages 20 and
50. More importantly, the genes which influence a pheno-
type late in life may not have an influence early in life and
vice versa.
In this report, the Framingham Heart Study (FHS) longi-
tudinal data collection scheme and genome scan data are
used to explore linkage signals for selected quantitative
trait loci (QTL) over time. The traits of interest (height,
weight, body mass index (BMI) and SBP) are used within
specific time windows to develop a better understanding
of the penetrance of a disease over time. Since height var-
ies modestly between the ages of 30 and 80, it is used as a
contrast to traits that likely exhibit age-dependent envi-
ronmental and genetic influences. In addition, these anal-
yses may help identify regions of the genome that may
harbor QTL.
Methods
The FHS recruited a total of 10,333 individuals from two
cohorts to participate in research whose aim was to mon-
itor and identify common factors related to CVD. The
original cohort (Cohort) led to recruitment of a second
cohort (Offspring) in which spouses and children of the
Cohort were ascertained. Over the years the study enrolled
1644 spouse pairs, 2616 offspring, and 34 stepchildren.
The most informative 330 pedigrees were submitted for
genome scan to the NHLBI-supported Mammalian Geno-
typing Service (MGS), which typed 428 markers with an
average distance between markers of approximately 8.4
cM. The pedigrees contained 4692 individuals, of which
2885 had DNA for genetic studies. It is from this sample
that our sample was constructed. Our sample required
presence of both genotypic and phenotypic data from
three age categories centered at 40, 55, and 70 years for
each outcome and relevant covariates. These age catego-
ries included the nearest visit ± 9 years for ages 40 and 70
years; for age 55, an interval of ± 5 years was chosen. Une-
ven age categories were required to maximize the number
of individuals that have data in all three intervals. In addi-
tion, it is important that the different intervals span mean-
ingfully different periods of life. As a result of our
sampling strategy, the individuals used in the analyses
may vary between traits but not within a trait. Specifically,
individuals in the BMI analysis may not have been
included in the SBP analyses, but the same individuals are
used for each of the BMI analyses. For those individuals in
the age-stratified analysis, data from visit 7 and 3 from the
Cohort and Offspring, respectively, were used in the age-
adjusted analysis. An additional sample was constructed
by including data for a subject from a family in the sample
who was excluded from the original analyses due to death
before age 61. QTL analyses for each trait were performed
on the age group 40 data with the selected covariates for
each trait as well as adjusting for early death of an individ-
ual and their age of death.
QTL multipoint variance-component analyses were then
performed using Sequential Oligogenic Linkage Analysis
Routines (SOLAR) [2] at each age category with marker
allele frequencies being determined based upon the FHS
sample data. The maximum likelihood method for
hypothesis testing was performed using the relationship
of identity-by-descent (IBD) statistics between family
members and genetic covariance. The full model (QTL
effect accounting for a portion of the genetic variance)
with the null model (no QTL effect). In our analyses, only
a priori covariates were considered and they were directly
incorporated into the variance-component models with
SOLAR [3].
Traits for analysis included SBP, BMI, weight, and height.
In the Cohort, per FHS protocol, height was collected dur-
ing selected visits only. Height was inferred for each par-
ticipant using the previous height for visits in which a
participant attended, but this data was not collected (for
missing at the initial visit, height was inferred for each
time point using the first recorded measurement). Where
appropriate, traits were transformed to better approxi-
mate the distributional assumptions of conditional nor-
mality and homogeneity of variance. Collinearity and
influence were examined using standard linear regression
diagnostics [4]. These analyses suggested that height did
not require any transformation but SBP, weight, and BMI
were log-transformed. Weight was analyzed after adjust-
ing for gender and height. SBP was analyzed after adjust-
ing for gender and BMI. BMI and height were analyzed
after adjusting for gender. For those individuals in the age-
stratified analyses, data from FHS visit 7 and 3 from the
Cohort and Offspring, respectively, were used in the age-
adjusted analysis. An additional sample was constructed
by including data for a subject from a family in the sample
who was excluded from the original analyses due to death
before age 61. Similar QTL analyses for each trait were per-
formed on the age group 40 data with the selected covari-
ates for each trait as well as adjusting for early death of an
individual and their age of death.
Results
The basic characteristics on the collective sample of study
subjects, for both the age-stratified and age-adjusted anal-
yses, are summarized in Table 1. For the traits of interest,
participants, as they aged, were of shorter stature (height:
65.2 in, 65.0 in, 64.3 in) and more obese (BMI: 25.6 kg/
m2, 26.4 kg/m2, 27.1 kg/m2). Blood pressure increased
over time (SBP: 125.8 mm Hg, 131.7 mm Hg, 139.9 mmBMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S31
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Hg). The mean age at the last exam attended before death
was 71.8 (SD = 6.3, N = 229).
Using the genome scan data, the results for each age group
are presented for the selected phenotypes. The regions
presented in the tables reflect regions that provide some
support in at least one of the three age categories or the
age-adjusted analysis with multipoint LOD > 1.0. The
results for height adjusted by gender appear in Table 2.
The strongest evidence of linkage to height was at 14q.
Linkage to height was consistent for GATA74E02A
(D14S742) on the distal part of 14p (LOD = 2.38 in the
31–49 age group, LOD = 1.84 in the 50–60 age group, and
LOD = 2.45 in the 61–70 age group). The weakest evi-
dence for linkage at this marker is in the age-adjusted
analysis (LOD = 1.4508). No other marker had consist-
ently strong evidence of linkage for height (LOD > 2) in
any category. It is interesting to note that the modest evi-
dence for linkage at 12q (LOD = 1.03) coincides with the
region reported by Xu et al. [5].
The results for weight adjusted for height and gender are
shown in Table 3. The strongest evidence for linkage
occurs in the youngest age group (31–49), with LOD =
3.10 for GATA3C02 (D3S1744) and LOD = 2.47 for
ATA2E04 (D1S1588). Evidence for linkage at these mark-
ers significantly decreases with age, as no other marker
provides strong (LOD > 2) evidence in the older age
groups. The results for BMI (adjusted for gender) are
shown in Table 4. Similar to the results for weight, the
strongest evidence for linkage occurs in the youngest
group (31–45) with the same markers (GATA3C02, LOD
= 2.89, D3S1744; ATA2E04, LOD = 2.21, D1S1588). Also,
no other marker provided strong evidence for linkage
(LOD > 2). These results suggest a hypothesis that these
regions may harbor loci that influence obesity and that
they may more easily be detected in relatively younger
samples.
The strongest evidence for linkage in the age-stratified
analyses of SBP occurs near ATA82B02 in age group 61–
79 (LOD = 1.10) and GATA134B03 (D5S2845) in age
group 50–60 (LOD = 1.01). It is interesting to note that
these regions of interest showed virtually no evidence for
linkage in other age groups. In the age-adjusted analysis,
marker GATA188F04 (D21S2055) shows evidence for
linkage on 21q (LOD = 1.21). However, there was no evi-
dence for linkage in this region in the age-stratified
analysis.
Table 1: Demographic distribution of traits with selected covariatesA
Ages 31–49 Ages 50–60 Ages 61–70 Age-Adjusted Cohort Visit 
7 Offspring Visit 3
Age (3.3, 795) (1.0, 795) (3.2, 795) (5.7, 781)
Female (442) (442) (442) (442)
Height (in) (3.8, 792) (3.7, 792) (3.7, 792) (3.7, 778)
Weight (lbs) (29.4, 795) (25.9, 795) (31.3, 795) (30.5, 765)
BMI (kg/m2) (3.7, 792) (3.9, 792) (4.4, 792) (4.0, 762)
SBP (mm Hg) (16.2, 795) (18.5, 795) (20.6, 795) (18.2, 768)
Smoke (777) (795) (793) (767)
AData are listed in the format mean (SD) for continuous traits or % (N) for dichotomous traits.
Table 2: Genome-wide scan results for height adjusted by gender.
AGE 40 AGE 55 AGE 70 Age-Adjusted Cohort Visit 






















2 p 2 5 . 3 G A T A 1 6 5 C 0 7 1 . 5 20 – 1 31 . 1 40 – 1 60 . 8 80 – 2 00 . 9 40 – 2 2
12q13.13 GGAT2G06 0.70 36–96 1.03 0–104 0.62 36–102 1.05 36–114
1 4 q 1 1 . 2 G A T A 7 4 E 0 2 A 2 . 3 80 – 2 21 . 8 40 – 2 42 . 4 50 – 2 71 . 4 50 – 2 4
19p13.3 GATA21G05 0.48 0–56 1.03 0–101 1.48 0–56 0.48 0–44BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S31
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Discussion
The age-stratified analyses explored in this study are
restricted to a few cardiovascular- and anthropometric-
related traits, which may exhibit age-dependent (e.g.,
BMI) and age-independent (e.g., height) penetrances.
These analyses provide an interesting contrast in study
design over that of an age-adjusted analysis from a specific
clinic visit. The results from the age-stratified analyses for
one potentially age-dependent trait, BMI, yielded larger
maximum LOD scores in the younger stratum than the
older stratum or age-adjusted analysis. The reduced evi-
dence for linkage in the latter analyses may reflect the
increasing influences of environmental factors or different
genes working during different stages of life. The age-strat-
ified and age-adjusted analyses tended to yield more sim-
ilar maximum LOD scores for the likely age-independent
trait, height.
Given the sample selection criteria, subjects were excluded
from our original analyses who may have exhibited
greater severity of BMI, weight, and SBP. In looking at
causes of morbidity and mortality, Kim et al. [6] showed
a positive linear relationship between CHD and BMI.
Censoring of data due to morbidity and mortality from
changing risk factor distribution may have occurred,
affecting the contribution of those at the extremes of the
phenotypic distribution. The impacts of these fatalities
were examined, but neither height, weight, BMI, nor SBP
exhibited any significant evidence for linkage.
Garrison et al. [7] showed smoking to be a potential con-
founder of the relationship between obesity and
mortality. Additional analyses were computed adjusting
SBP for smoking status (i.e., yes, no), since smoking status
is positively correlated with SBP. However, no substantial
differences in the linkage results were observed.
While this examination of the data yielded no significant
results on chromosome 6 for BMI, which has been previ-
ously reported by Atwood et al. [8]. At least three reasons
may contribute to this result. First, our sampling scheme
was more restrictive. Second, in the sample employed in
Table 3: Genome-wide scan results for weight adjusted by gender and height.
AGE 40 AGE 55 AGE 70 Age-Adjusted Cohort Visit 























1p22.1 ATA2E04 2.47 119–140 0.85 98–170 0.54 114–148 0.58 106–150
3q22 GATA3C02 3.10 155–171 1.17 146–180 0.99 148–200 1.03 152–188
6p21.2 GTAT1H06 1.12 18–90 0.94 20–98 0.34 26–64 1.65 29–61
8p21.3 COS140D4 1.38 24–64 1.49 24–63 0.90 18–80 1.08 12–64
1 2 p 1 3 . 3 2 G A T A 4 H 0 3 0 . 3 70 – 3 01 . 7 70 – 1 50 . 8 80 – 3 21 . 0 20 – 7 0
17q25.3 AFM044xg3 1.68 101–126 0.91 82–126 0.71 74–116 0.35 88–126
18p11.31 GATA88A12 1.70 0–44 1.36 0–46 0.40 0–34 1.08 0–42
Table 4: Genome-wide scan results for BMI adjusted by gender.
AGE 40 AGE 55 AGE 70 Age-Adjusted Cohort Visit 























1p22.1 ATA2E04 2.21 119–41 0.56 96–152 0.44 68–146 0.37 108–150
3q22 GATA3C02 2.89 156–175 0.95 70–138 0.97 150–200 0.96 150–190
8p21.3 COS140D4 1.45 42–63 1.51 24–62 0.87 18–78 1.02 10–64
12p13.32 GATA4H03 0.60 0–30 1.85 0–14 0.85 0–30 1.07 0–52
17q25.3 AFM044xg3 1.58 100–126 0.90 80–126 0.75 72–116 0.38 86–126
18p11.31 GATA88A12 1.74 0–43 1.34 0–46 0.49 0–34 1.14 0–38BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S31
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our analyses, BMI was log-transformed to better approxi-
mate distributional assumptions. Third, the age-stratified
analysis presented here does not provide for a cohort
adjustment. Such adjustment may minimize the genera-
tional differences in exercise, eating habits, medical care,
etc., that has varied over the decades.
Conclusions
When taking into account the many changes that occur
within the human body throughout life, it seems highly
plausible that variation in a phenotype with some genetic
component may be affected by different genetic loci at dif-
ferent times. Given this scenario, an age-adjusted analysis
would not necessarily optimally define these regions.
While the correlation in the different age-stratified
genome scans can be observed in Figures 1 and 2, there are
also differences in the magnitude of the LOD scores at
1p22.1 and 3q22 for weight and BMI. The change in BMI
from age group 40 to 55 and 70 is the only source of var-
iation between the scans of these age groups. Age-strati-
fied analyses may help to better identify regions which
play a role in determining early and/or late gene expres-
sion or those which are constantly expressed. Thus, age-
adjusted and age-stratified analysis plans provide comple-
mentary tools in the search for genes which influence
traits.
Chromosome 1 genome scan for BMI adjusted by gender Figure 1
Chromosome 1 genome scan for BMI adjusted by gender.BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S31
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Chromosome 3 genome scan for BMI adjusted by gender Figure 2
Chromosome 3 genome scan for BMI adjusted by gender.
Table 5: Genome-wide scan results for SBP adjusted by gender and BMI.
AGE 40 AGE 55 AGE 70 Age-Adjusted Cohort 























5p14.3 GATA134B03 0.02 32–42 1.01 0–44 0.27 14–54 0.53 0–70
18q22.3 ATA82B02 0.00 -A 0.00 106–108 1.10 74–116 0.0000 0–102
21q22.2 GATA188F04 0.00 22–26 0.66 - 0.04 16–28 1.21 22–58
A-, denotes the entire length of the genotyped chromosome.Publish with BioMed Central    and   every 
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